Match tier
Likely match
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
S
Sydnye Shuttlewoth
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Also affiliated: Arkansas Department of Agriculture (2026)
Graduate Student Researcher
1 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Sydnye Shuttlewoth's research focuses on advancing cancer immunotherapy and understanding disease resistance mechanisms. Her work includes characterizing the activation of ATF6, a transcription factor, to enhance the effectiveness of immune checkpoint blockade (ICB) therapy. Additionally, she investigates strategies to generate CAR-T cells resistant to EZH2 inhibitors, aiming to prolong their therapeutic function in combination treatments. Shuttlewoth has one publication in the field of molecular biology and immunology.
Metrics
- Publications: 1
Selected Publications
-
Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy (2026)
-
Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy (2026)
Collaboration Network
Top Collaborators
Katherine Bronson
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Daniel Fil
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Megan R. Reed
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Billie Heflin
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Brian Koss
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Alan J. Tackett
University of Arkansas for Medical Sciences
2 shared publications
In database
- Abstract 5189: Generating EZH2-inhibitor resistant CAR-T cells to sustain function for combination therapy
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Sanjay Adhikary
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Jacob L Edmondson
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Duah Alkam
Winthrop Rockefeller Foundation
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Katherine Wallis
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Nathan L. Avaritt
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Sean D. Taverna
University of Arkansas for Medical Sciences
1 shared publication
In database
- Abstract 6545: Characterizing ATF6 activation-driven mechanisms improving ICB efficacy
Similar Researchers
Based on overlapping research topics
A. H. Fowler
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Carlon Q Gragg
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
M. R. Wren
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Yan Cheng
University of Arkansas for Medical Sciences
Cancer Immunotherapy and Biomarkers
Immune Response and Inflammation
Disease Mechanisms Research
Roger G. Rank
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications
Azemat J. Parsian
University of Arkansas for Medical Sciences
Immune Response and Inflammation
Disease Mechanisms Research
Molecular Biology Techniques and Applications